Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
(2001) showed that topical BPC-157 outperformed silver sulfadiazine and systemic corticosteroids in mouse burn models
Multiple Injury Sites If you have injuries in more than one location -- a bad shoulder and a bad knee, for example -- BPC-157's systemic action covers multiple sites with a single daily injection
This method is designed to maintain product integrity and allows vials to remain stable during shipping for approximately 34 months
Inositol Inositol is lipotropic which is related to the Vitamin B family
The strong safety profile supports extended, medically supervised protocols without the concerns tied to NSAIDs or corticosteroids
In simplified terms: BPC-157 research focuses on signaling repair to begin, while TB-500 research focuses on enabling cells to physically reach the repair site
